Press Releases
Abbott Wins Two Scrip Awards Recognizing Excellence in Pharmaceutical and Biotech Industries
Abbott Park, Illinois Scrip, a leading global pharmaceutical and biotech news organization, honored Abbott with two 2010 Scrip Awards for its business excellence and...
News
Merck To Present Innovative Products for Displays at the FPD International in Makuhari (Japan)
Merck KGaA announced today that it will be exhibiting at the FPD International, one of the leading events for the flat panel display...
Clinical Trials
Genentech announced the result of Phase II clinical trail of RG7204
Genentech, Inc., a member of the Roche Group announced results from a Phase II clinical study of RG7204 (PLX4032), an investigational first-in-class molecule designed...
Drug Research
Prolia(TM) (denosumab) Receives Best New Drug Honor at Scrip Awards
Amgen announced that it has won the Best New Drug awardfor Prolia(TM) (denosumab), a novel treatment approved in the United States (U.S.)...
Clinical Trials
Sanofi Pasteur’s Dengue Vaccine in Final Stage of Clinical Development
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced that its dengue vaccine is in final stage of clinical development. Sanofi Pasteur’s dengue vaccine,...
News
Eli Lilly and Company received FDA approval for Cymbalta
Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved Cymbalta® (duloxetine HCl) for the management of chronic musculoskeletal...
Research Insight
New data show potential for Novartis Meningitis B vaccine candidate to cover majority of diverse meningococcal serogroup B strains
New data demonstrated that antibodies induced by Novartis Vaccines investigational, four component, Meningococcal Serogroup B Vaccine (4CMenB) killed the majority of a collection of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read